BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 23528864)

  • 41. Minimally invasive adenocarcinomas of the lung.
    Dacic S
    Adv Anat Pathol; 2009 May; 16(3):166-71. PubMed ID: 19395880
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Adenocarcinomas of the urachus].
    Salinas Sánchez AS; Alcalá-Santaella Casanova C; Martínez Martín M; Pastor Guzmán JM; Cañamares Pabolaza L; Virseda Rodríguez J
    Arch Esp Urol; 1991; 44(1):31-6. PubMed ID: 1648342
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [A case of metastatic pulmonary cancer from urachal carcinoma that required differentiation from primary lung adenocarcinoma].
    Tatsuno M; Tamura S; Taniguchi F; Yasuoka H; Nasu H; Fujimoto T
    Nihon Kokyuki Gakkai Zasshi; 2011 Nov; 49(11):848-54. PubMed ID: 22171490
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comprehensive Molecular Characterization of Urachal Adenocarcinoma Reveals Commonalities With Colorectal Cancer, Including a Hypermutable Phenotype.
    Kardos J; Wobker SE; Woods ME; Nielsen ME; Smith AB; Wallen EM; Pruthi RS; Hayward MC; McGinty KA; Grilley-Olson JE; Patel NM; Weck KE; Black P; Parker JS; Milowsky MI; Hayes DN; Kim WY
    JCO Precis Oncol; 2017; 1():. PubMed ID: 32913973
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A novel treatment approach prolonging survival in an uncommon metastatic primary bladder adenocarcinoma.
    Pokuri VK; Sule N; Perfetto C; Duff M; Kopp C; Guru K; Shah D; George S
    J Community Support Oncol; 2016 Feb; 14(2):72-5. PubMed ID: 26955660
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Brain metastasis from urachal carcinoma.
    Takahara K; Mochizuki Y; Ichimura S; Kurebayashi Y; Fujii K
    Surg Neurol Int; 2019; 10():152. PubMed ID: 31528487
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular characterization of colorectal mucinous adenocarcinoma and adenocarcinoma, not otherwise specified, identified by multiomic data analysis.
    Xu K; Zheng S; Li B; Shao Y; Yin X
    Front Mol Biosci; 2023; 10():1150362. PubMed ID: 37091868
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Novel Approach to Treatment with Antiangiogenic Agents in Adenocarcinoma of Urachal Origin.
    Yu J; Wang CG; Zhang Y; Yang W; Chen F
    Urology; 2024 May; 187():121-122. PubMed ID: 38467287
    [No Abstract]   [Full Text] [Related]  

  • 49. Urachal adenocarcinoma.
    Aparicio-López D; Cerdán Pascual R; Cantín Blázquez S; Ligorred Padilla LA
    Cir Esp (Engl Ed); 2023 Dec; 101(12):867-869. PubMed ID: 36572244
    [No Abstract]   [Full Text] [Related]  

  • 50. Observations on the Nature of Mucin Secreting Urachal Cystadenoma.
    Elliott GB; Freigang B
    Ann Surg; 1963 Apr; 157(4):613-7. PubMed ID: 17859733
    [No Abstract]   [Full Text] [Related]  

  • 51. Urachal carcinoma: from gross specimen to morphologic, immunohistochemical, and molecular analysis.
    Riva G; Mian C; Luchini C; Girolami I; Ghimenton C; Cima L; Novelli L; Hanspeter E; Mazzoleni G; Schwienbacher C; Pycha S; D'Elia C; Trenti E; Pycha A; Martignoni G; Hes O; Eccher A; Nesi G; Brunelli M
    Virchows Arch; 2019 Jan; 474(1):13-20. PubMed ID: 30302546
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Surgical treatment of recurrent urachal carcinoma with liver metastasis: a case report and literature review.
    Paschke L; Juszczak M; Slupski M
    World J Surg Oncol; 2016 Nov; 14(1):296. PubMed ID: 27894318
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genetics and biological markers in urachal cancer.
    Behrendt MA; van Rhijn BW
    Transl Androl Urol; 2016 Oct; 5(5):655-661. PubMed ID: 27785422
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunohistochemical analysis in a morphologic spectrum of urachal epithelial neoplasms: diagnostic implications and pitfalls.
    Paner GP; McKenney JK; Barkan GA; Yao JL; Frankel WL; Sebo TJ; Shen SS; Jimenez RE
    Am J Surg Pathol; 2011 Jun; 35(6):787-98. PubMed ID: 21572312
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Updates in the Pathologic Diagnosis and Classification of Epithelial Neoplasms of Urachal Origin.
    Paner GP; Lopez-Beltran A; Sirohi D; Amin MB
    Adv Anat Pathol; 2016 Mar; 23(2):71-83. PubMed ID: 26849813
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinicopathologic features and utility of immunohistochemical markers in signet-ring cell adenocarcinoma of the bladder.
    Thomas AA; Stephenson AJ; Campbell SC; Jones JS; Hansel DE
    Hum Pathol; 2009 Jan; 40(1):108-16. PubMed ID: 18789486
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Urachal carcinomas of the nonglandular type: salient features and considerations in pathologic diagnosis.
    Paner GP; Barkan GA; Mehta V; Sirintrapun SJ; Tsuzuki T; Sebo TJ; Jimenez RE
    Am J Surg Pathol; 2012 Mar; 36(3):432-42. PubMed ID: 22301493
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enteric type urachal adenocarcinoma: a case report.
    El Demellawy D; Nasr A; Alowami S; Escott N
    Can J Urol; 2009 Aug; 16(4):4753-6. PubMed ID: 19671231
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The different morphologies of urachal adenocarcinoma do not discriminate genomically by micro-RNA expression profiling.
    Bissonnette ML; Kocherginsky M; Tretiakova M; Jimenez RE; Barkan GA; Mehta V; Sirintrapun SJ; Steinberg GD; White KP; Stricker T; Paner GP
    Hum Pathol; 2013 Aug; 44(8):1605-11. PubMed ID: 23528864
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.